Headache
Migraine Abortive Treatment
search
Migraine Abortive Treatment
, Migraine Abortive Management
See Also
Migraine Headache
Migraine Headache Management
Migraine Headache Management in Children
Emergency Department Migraine Headache Care
Migraine Medications in Pregnancy
Migraine Medications in Breast Feeding
Headache in Pregnancy
Management
Gene
ral Pointers
Consider abortive agent sparing measures
See
Headache General Measure
s
See
Migraine Prophylaxis
Establish
Migraine Management Clinic Schedule
Evaluate acute
Headache
regimen with standardized symptom score
Migraine
Treatment Optimization Questionnaire (M-TOQ)
Lipton (2009) Cephalalgia 29(7):751-9 [PubMed]
Serrano (2015) Headache 55(4):502-18 [PubMed]
Migraine
Assessment of Current Therapy (
Migraine
-ACT)
Dowson (2004) Neurol Sci 25 Suppl 3:S276-8 +PMID:15549559 [PubMed]
Kilminster (2006) Headache 46(4):553-62 [PubMed]
Avoid use of abortive agents more than twice per week
Frequent use results in
Rebound Headache
NSAID
s are unlikely to cause
Rebound Headache
Gastrointestinal motility drugs improve efficacy
Metoclopramide
(
Reglan
)
Dose: 10 mg PO 20-30 minutes before pre-medication
Extrapyramidal Side Effect
s
Dystonic Reaction
(especially in children)
Antiemetic
effect in addition to increased motility
Antiemetic
s may be very useful in abortive treatment
Alleviate
Nausea
associated with
Headache
Sedation to allow rest despite
Headache
Increases medication absorption (e.g.
Reglan
)
Combined therapies may be helpful in refractory cases
Aspirin
and
Metoclopramide
Aspirin
975 mg PO (three 325 mg tablets)
Metoclopramide
(
Reglan
) 10 mg PO
DHE and
Vistaril
Combination
DHE-45
1 mg IM
Vistaril
75 mg IM
Management
Serotonin Agonist
s
Triptan
s
Sumatriptan
(
Imitrex
)
Rizatriptan
(
Maxalt
)
Zolmitriptan
(
Zomig
)
Naratriptan
(
Amerge
)
Ergotamine
s (do not use within 24 hours of
Triptan
s)
Dihydroergotamine
(
DHE-45
)
Ergotamine
Management
Oral Analgesic
s
Gene
ral
Beware
Rebound Headache
s with most
Analgesic
s
Analgesic
s with proven efficacy
Excedrin
Migraine
(
Acetaminophen
,
Aspirin
,
Caffeine
)
Aspirin
975 mg PO (with or without
Metoclopramide
)
Midrin (Isometheptene, Dichloralphenazone,
Tylenol
)
Dose: 2 stat at
Headache
onset
Repeat 1 each hour prn
Maximum: 5 pills per 12 hours, 20 pills per month
Limit use to no more than 2 days per week
Anaprox
,
Aleve
(
Naproxen
Sodium
)
Absorbed more rapidly than
Naprosyn
Initial Dose: 825 mg (Three 275 mg tablets)
Repeat 220 to 550 mg every 3-4 hours
Maximum: 1.5 grams per day (5 to 6 tablets per day)
Analgesic
s to be avoided (low efficacy and higher risk)
Cafergot (
Ergotamine
with
Caffeine
)
Dose: 2 PO stat with
Headache
onset
Repeat one tablet every half hour prn
Maximum: 4 to 6 pills per day or 10 per week
Fiorinal (ASA 325mg,
Caffeine
40mg, Butalbital 50mg)
Dose: 2 tablets at
Headache
onset
Repeat one tablet every 4 to 6 hours prn
Maximum: 5 pills per day or 15 per month
Limit use to no more than 2 days per week
Risk of
Rebound Headache
s with use more than 5 days per month
Esgic or Fioricet (
Tylenol
,
Caffeine
, Butalbital)
Same dosing recommendations and precautions as for Fiorinal
Precaution: Pharmaceutical obfuscation alert
Fioricet brand name capsules (Watson) as of 2014 will contain 300 mg
Acetaminophen
(at 4x the generic cost)
Fioricet generic tablets will contain 325 mg
Acetaminophen
(making automatic substitution difficult)
One more reason not to prescribe fioricet (other
Migraine
abortive agents are preferred)
(2014) Presc Lett 21(3)
Management
Parenteral
Analgesic
s
See
Emergency Department Migraine Headache Care
See
Serotonin Agonist
s (
Triptan
s) below
See
Opioid
s below (avoid if possible)
Ketorolac
(
Toradol
)
Dose: 30-60 mg IM
May repeat 15-30 mg q6h
Do not exceed 5 consecutive days of use
May supplement with rectal
Antiemetic
Management
Rectal
Analgesic
s (indicated for
Vomiting
)
Rectal
Antiemetic
s
Promethazine
(
Phenergan
) 12.5 to 25 mg PR q4-6 hours
Prochlorperazine
(
Compazine
) 25 mg PR q12 hours
Rectal
Analgesic
s
Indomethacin
50 mg, 1-2 PR at
Headache
onset
Serotonin Agonist
Ergotamine
tartrate (
Wigraine
) suppository
Use
Ergotamine
with caution due to adverse effects
Management
Third-line Agents
Precautions
Expensive agents ($85 per tablet in 2020)
Half the efficacy than
Triptan
s
Indications
Indicated in
Migraine
s refractory to at least two first-line
Triptan
s
Evaluate efficacy with standardized symptom score (see above)
Gepant
(CGRP receptor blocker)
Ubrogepant
(
Ubrelvy
)
Rimegepant
(
Nurtec
)
Ditan
(Selective Serotonin
5-Hydroxytryptamine
receptor 1F agonst or
5-HT
1F
Agonist
)
Schedule V due to euphoria and
Hallucination
s
Lasmiditan
(
Reyvow
)
Management
Opioid
s
Gene
rally avoid
Opioid
s in chronic
Headache Management
Indications
Patients failing non-
Opioid
therapy
Much less desirable for
Headache Management
Non-specific for
Headache
Addictive potential
Stadol-NS (Butorphanol)
Addictive (Class IV regulated substance)
High abuse potential
Dosing
Stadol 1 spray in one nostril, repeat hourly prn
Maximum 4 sprays per day or 6 sprays per week
Limit to 2 days per week
References
(1995) Med Lett Drugs Ther 37(943) [PubMed]
Moore (1997) Am Fam Physician 56(8):2039-48 [PubMed]
Jackson (1998) CMEA Internal Medicine Lecture,San Diego
Noble (1997) Am Fam Physician 56(9):2279-86 [PubMed]
Type your search phrase here